Therapeutic effects of propolis, royal jelly, ostrich oil, and Aloe vera on cutaneous Leishmaniasis lesions in a laboratory model

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 201

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARMMT-5-1_001

تاریخ نمایه سازی: 2 خرداد 1402

چکیده مقاله:

In recent decades, effective herbal and natural compounds have been formulated with topical application, reduced side effects, and more economic benefits for Cutaneous Leishmaniasis (CL) treatment. Some of these include Propolis, Royal jelly, Ostrich oil, and Aloe Vera, which have widespread use in health products. The study aimed to evaluate the potential therapeutic effects of a prepared topical combination, including Propolis, Royal jelly, Ostrich oil, and Aloe Vera, on Leishmania major lesions under an in vivo model in BALB/c (concatenation of Bagg and Albino) mice. Fifty BALB/c mice were randomly divided into five groups of ten. CL lesions were induced by inoculation of metacyclic promastigotes at the base of the BALB/c mice's tails. The resulting lesions were treated topically with prepared natural combinations of Propolis, Royal jelly, Ostrich oil, and Aloe Vera. The lesion sizes were determined as the mean ± standard deviation. One-way analysis of variance (ANOVA) with the Bonferroni correction method was used for statistical analysis, with p < ۰.۰۵ considered statistically significant. Based on the data of this research, comparative ulcer size reductions were ۶۳.۴% (۳.۲۵ mm ± ۰.۲۴), ۶۸.۴% (۳.۵۵ mm ± ۰.۲۲), and ۸.۵% (۰.۴۴ mm ± ۰.۹۸) for the natural combination treatment ۱, treatment ۲, and Glucantime, respectively. Based on the results, the proposed natural combinations were significantly more effective at reducing ulcer size than Glucantime, the standard drug (p<۰.۰۵). Collectively, we conclude that a combination consisting of Propolis, Royal jelly, Aloe Vera, and ostrich oil is effective in treating CL in mice and may provide a new agent in the treatment of Leishmaniasis.

نویسندگان

Mohsen Mahmoudi

Department of Parasitology and mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Sedigheh Saberi

Department of Parasitology &amp; Mycology, Faculty of medicine, Esfahan University of Medical Sciences, Esfahan, Iran

Parham Manouchehri

Biomedical Research Centre, University of Salford, Greater Manchester, England

Mehdi Mohebali

Department of Parasitology and mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Mahboobe Parsaeian

Department of Epidemiology and Biostatistics. School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Zahra Hesari

Department of Pharmaceutics, School of Pharmacy, Gilan University of Medical Sciences, Rasht, Iran

Marjan Seratnahaei

Department of Microbiology, North Tehran Branch, Islamic Azad University, Tehran, Iran

Helia Behrouzfar

Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran

Alireza Zahraei-Ramazani

Department of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.